Contrasting effects of chronic paroxetine on 5-HT(1A) control of dorsal raphe cell firing and 5-HT release

NeuroReport

Volumn 9, Issue 11, 1998, Pages 2535-2538

  Davidson, Colin ^a   Stamford, Jonathan A ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

5 HT release; 5 HT(1A) autoreceptor; 8 Hydroxy DPAT; Brain slice; Dorsal raphe nucleus; Paroxetine; Voltammetry

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; PAROXETINE; PHENYLEPHRINE; RECEPTOR SUBTYPE; SEROTONIN 1A AGONIST; SEROTONIN 1A RECEPTOR; SEROTONIN RECEPTOR; SEROTONIN UPTAKE INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; DEPRESSION; DORSAL RAPHE NUCLEUS; DRUG EFFECT; MALE; NEUROPHARMACOLOGY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SEROTONIN RELEASE; SEROTONINERGIC TRANSMISSION;

EID: 0032479831     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199808030-00020     Document Type: Article

References (19)

1. Bliere P and de Montigny C. Trends Pharmacol Sec 15, 220-226 (1994).
2. Blier P, de Montigny C and Chaput Y. J Clin Psychiat 51 (Suppl), 14-20 (1990).
3. Cox RF, Meller E and Waszczak BL. Synapse 14, 297-304 (1993).
4. O'Connor JJ and Kruk ZL. Br J Pharmacol 106, 524-532 (1992)
5. Sprouse JS and Aghajanian GK. Synapse 1, 3-9 (1987).
6. O'Connor JJ and Kruk ZL. J Neurosci Methods 38, 25-33 (1991).
7. Davidson C and Stamford JA. Br J Pharmacol 114, 357P (1995).
8. Moret C and Briley M. Eur J Pharmacol 180, 351-356 (1990).
9. O'Connor JJ and Kruk ZL. Brain Res 640, 328-335 (1994).
10. Blier P, Chaput Y and de Montigny C. Naunyn Schmiedebergs Arch Pharmacol 337, 246-254 (1988).
11. Chaput Y, de Montigny C, and Blier P. Naunyn Schmiedebergs Arch Pharmacol 333, 342-345 (1986).
12. Hjorth S and Auerbach SB. Neuropharmacology 33, 331-334 (1994).
13. Kheck NM, Gannon PJ and Azmitia EC. J Comp Neurol 355, 211-220 (1995).
14. Li Q, Battaglia G and Van de Kar LD. Brain Res 769, 141-151 (1997).
15. Johnson RG, Fiorella D, Winter JC and Rabin RA. Eur J Pharmacol 329, 99-106 (1997).
16. Haj-Dahmane S, Hamon M and Lanfumey L. Neuroscience 41, 495-505 (1991).
17. Bayliss DA, Li Y-W and Talley EM. J Neurophysiol 77, 1349-1361 (1997).
18. Cardenas CG, Del Mar LP and Scroggs RS. J Neurophysiol 77, 3284-3296 (1997).
19. Davidson C and Stamford JA. Br J Pharmacol 114, 1107-1109 (1995).